Drug Shortage Report for NITROGLYCERIN IN 5% DEXTROSE INJ.-400MCG/ML
Report ID | 82898 |
Drug Identification Number | 02145316 |
Brand name | NITROGLYCERIN IN 5% DEXTROSE INJ.-400MCG/ML |
Common or Proper name | NITROGLYCERIN IN 5% DEXTROSE INJ.-400MCG/ML |
Company Name | BAXTER CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | DEXTROSE NITROGLYCERIN |
Strength(s) | 5G 40MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 250 mL |
ATC code | C01DA |
ATC description | VASODILATORS USED IN CARDIAC DISEASES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2019-05-01 |
Actual start date | 2019-05-01 |
Estimated end date | 2019-05-21 |
Actual end date | 2019-05-21 |
Shortage status | Resolved |
Updated date | 2019-05-22 |
Company comments | JA0694 - 50mg/250mL NITROGLYCERIN IN 5% DEX INJ is available as an alternative (DIN: 02145308) . For availability contact Baxter customer care (1.888.719.9955). |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2019-05-22 | English | Compare |
v5 | 2019-05-21 | French | Compare |
v4 | 2019-05-21 | English | Compare |
v3 | 2019-05-02 | English | Compare |
v2 | 2019-05-01 | French | Compare |
v1 | 2019-05-01 | English | Compare |
Showing 1 to 6 of 6